交易中 09-16 15:32:10 美东时间
-0.010
-0.40%
文章来源:药智网 图片来源:摄图网 免费领取药智数据VIP试用 https://vip.yaozh.com/introducemobile?tryout...
08-21 11:06
Puma Biotechnology Inc - Wyeth Filed Motion Requesting Supplemental Damages for...
08-07 21:14
Puma Biotechnology- on Aug 6 Court Found AstraZeneca Had Not Proved Claim That ...
08-07 21:13
Puma Biotechnology Inc - AstraZeneca Has Filed a Motion Challenging Jury's Aug ...
08-07 21:13
Third Quarter and Full Year 2024 Financial Outlook Third Quarter 2024Full Year 2024Net Product Revenue$50 -53 million$183 - $190 millionRoyalty Revenue$20 - $22 million$30 - $33 millionLicense Revenue$0 million$1 -
08-02 05:38
Puma Biotechnology (NASDAQ:PBYI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. The company reported quarterly sales of $47.100 million which beat
08-02 04:58
Puma Biotechnology Inc -Sees Full Year 2024 Net Product Revenue $183 - $190 Mil...
08-02 04:46
Puma Biotechnology Inc -Sees Third Quarter 2024 Net Product Revenue $50 Mln-53 ...
08-02 04:46
During the last three months, 5 analysts shared their evaluations of Puma Biote...
07-27 05:01
HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.
07-27 04:01